Pulmonary hypertension trials recruiting in Oregon

All Pulmonary hypertension trials nationally

Cities in Oregon

Recruiting trials in Oregon

• A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
  NCT07816185 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · Oregon: Bend
• An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT07234032 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Oregon: Bend
• An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
  NCT06129240 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · Oregon: Bend
• DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT06388421 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Oregon: Bend, Portland
• Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT07179380 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Oregon: Bend
• Pulmonary Hypertension Association Registry
  NCT04071327 · Phase: Not specified · Ages: 0 Years and older · Sex: All (male and female) · Oregon: Portland
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
  NCT06526195 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Oregon: Portland